NLS CDMO

Following the outcome of the DIAGNODE-3 study, the company’s immediate priority is to complete the close-out of the Phase 3 program in an efficient and responsible manner, it states.

The company has now received GMP (Good Manufacturing Practice) certification as well as manufacturing authorization from the Swedish Medical Products Agency for the production of biological investigational medicinal products for human use.

The company has established manufacturing capacity in accordance with current quality requirements and regulatory guidelines, it states.

CEPI and the Recipharm company Analysis Zero have announced a new seed collaboration to advance the use of Nuclear Magnetic Resonance (NMR) as a real-time Process Analytical Technology (PAT) for RNA vaccine manufacturing.

Nanologica has received an order of appx. SEK 2 million for the company’s silica-based purification media NLAB Saga.

When His Royal Highness Prince Daniel and visitors from the Royal Swedish Academy of Engineering Sciences visited NorthX Biologics up in Matfors in northern Sweden, the company chose a somewhat different approach.